drugset / Trial / NCT03694405
Adolescent MenACWY Booster Study
Phase 4
Completed
244 enrolled
Canadian Immunization Research Network
Alberta Health services · collabBritish Columbia Centre for Disease Control · collabCanadian Center for Vaccinology · collabCanadian Institutes of Health Research (CIHR) · collabDalhousie University · collabUniversity of British Columbia · collabUniversity of Calgary · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
This study is to confirm non-inferiority of the three MenACWY vaccines (Menveo, Menactra or Nimenrix) in adolescents, and to identify whether the number of previous doses of MenC influences the response to the MenACWY vaccine.
Timeline
- Start
- 2018-09-20
- Primary completion
- 2021-08-01
- Completion
- 2021-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MenACWY-DT | Vaccine | — | — |
| Subject | Menveo | Vaccine | — | — |